Artiva Biotherapeutics, Short Ratio vs. Shares Owned By Institutions
| ARTV Stock | 10.48 0.63 5.67% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Return On Equity | 0.16 | 0.1709 |
|
|
For Artiva Biotherapeutics, profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Artiva Biotherapeutics, to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Artiva Biotherapeutics, Common utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Artiva Biotherapeutics,'s most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Artiva Biotherapeutics, Common over time as well as its relative position and ranking within its peers.
Artiva |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Artiva Biotherapeutics,. If investors know Artiva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Artiva Biotherapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.48) | Revenue Per Share 0.485 | Quarterly Revenue Growth (0.75) | Return On Equity (0.44) |
The market value of Artiva Biotherapeutics, is measured differently than its book value, which is the value of Artiva that is recorded on the company's balance sheet. Investors also form their own opinion of Artiva Biotherapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Artiva Biotherapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Artiva Biotherapeutics,'s market value can be influenced by many factors that don't directly affect Artiva Biotherapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Artiva Biotherapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Artiva Biotherapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Artiva Biotherapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Artiva Biotherapeutics, Shares Owned By Institutions vs. Short Ratio Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Artiva Biotherapeutics,'s current stock value. Our valuation model uses many indicators to compare Artiva Biotherapeutics, value to that of its competitors to determine the firm's financial worth. Artiva Biotherapeutics, Common is number one stock in short ratio category among its peers. It is rated second in shares owned by institutions category among its peers producing about 4.35 of Shares Owned By Institutions per Short Ratio. Comparative valuation analysis is a catch-all technique that is used if you cannot value Artiva Biotherapeutics, by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Artiva Shares Owned By Institutions vs. Short Ratio
Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Artiva Biotherapeutics, |
| = | 20.47 X |
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Artiva Biotherapeutics, |
| = | 89.07 % |
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Artiva Shares Owned By Institutions Comparison
Artiva Biotherapeutics, is currently under evaluation in shares owned by institutions category among its peers.
Artiva Biotherapeutics, Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Artiva Biotherapeutics,, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Artiva Biotherapeutics, will eventually generate negative long term returns. The profitability progress is the general direction of Artiva Biotherapeutics,'s change in net profit over the period of time. It can combine multiple indicators of Artiva Biotherapeutics,, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 277.2 K | 246.4 K | |
| Net Interest Income | 2.5 M | 2.7 M | |
| Interest Income | 2.5 M | 2.7 M | |
| Operating Income | -30.7 M | -32.2 M | |
| Net Loss | -27.7 M | -29.1 M | |
| Income Before Tax | -27.6 M | -29 M | |
| Total Other Income Expense Net | 3 M | 3.2 M | |
| Net Loss | -28.7 M | -30.2 M | |
| Income Tax Expense | 72 K | 75.6 K | |
| Net Loss | (2.96) | (3.11) | |
| Income Quality | 1.65 | 1.73 | |
| Net Income Per E B T | 1.00 | 0.80 |
Artiva Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Artiva Biotherapeutics,. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Artiva Biotherapeutics, position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Artiva Biotherapeutics,'s important profitability drivers and their relationship over time.
Use Artiva Biotherapeutics, in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Artiva Biotherapeutics, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Artiva Biotherapeutics, will appreciate offsetting losses from the drop in the long position's value.Artiva Biotherapeutics, Pair Trading
Artiva Biotherapeutics, Common Pair Trading Analysis
The ability to find closely correlated positions to Artiva Biotherapeutics, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Artiva Biotherapeutics, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Artiva Biotherapeutics, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Artiva Biotherapeutics, Common to buy it.
The correlation of Artiva Biotherapeutics, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Artiva Biotherapeutics, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Artiva Biotherapeutics, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Artiva Biotherapeutics, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Artiva Biotherapeutics, position
In addition to having Artiva Biotherapeutics, in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Services Thematic Idea Now
Services
Companies involved in delivering services to business or consumers across different industries and sectors. The Services theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Services Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Artiva Stock Analysis
When running Artiva Biotherapeutics,'s price analysis, check to measure Artiva Biotherapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Artiva Biotherapeutics, is operating at the current time. Most of Artiva Biotherapeutics,'s value examination focuses on studying past and present price action to predict the probability of Artiva Biotherapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Artiva Biotherapeutics,'s price. Additionally, you may evaluate how the addition of Artiva Biotherapeutics, to your portfolios can decrease your overall portfolio volatility.